6
A. ZIYAEI HALIMEHJANI ET AL.
s), 3.99–4.03 (4H, m), 4.99 (1H, s), 5.09 (1H, s) ppm; 13C NMR (125 MHz, CDCl3) δ 18.4,
26.1, 33.1, 40.0, 116.6, 140.4, 188.1, 202.6 ppm. Anal. Calcd for C8H11NOS2: C, 47.73; H,
5.51; N, 6.96. Found: C, 47.45; H, 5.36; N, 6.91.
2-(3-Methylbut-2-enylthio)thiazol-4(5H)-one (3g): IR (KBr) 1732, 1695, 1620, 1458,
1164, 991 cm−1; 1H NMR (500 MHz, CDCl3) δ 1.70 (3H, s), 1.73 (3H, s), 3.96–3.97 (4H,
m), 5.31 (1H, t, J = 8.0 Hz) ppm; 13C NMR (125 MHz, CDCl3) δ (ppm): 18.4, 26.1, 33.1,
40.0, 116.6, 140.4, 188.1, 202.6 ppm; MS (EI): m/z 201 (M)+, 187, 168, 146, 133, 114, 101,
86, 69, 55, 41 (100).
2-(Hexylthio)thiazol-4(5H)-one (3h): IR (KBr) 1732, 1708, 1458, 1168, 995 cm−1; 1H
NMR (500 MHz, CDCl3) δ 0.86 (3H, t, J = 7.0 Hz), 1.26–1.32 (4H, m), 1.38–1.42 (2H, m),
1.78 (2H, m), 3.31 (2H, t, J = 7.5 Hz), 3.96 (2H, s) ppm; 13C NMR (125 MHz, CDCl3) δ
14.4, 22.9, 28.7, 29.2, 31.6, 34.7, 39.9, 188.2, 202.8 ppm. Anal. Calcd for C9H15NOS2: C,
49.73; H, 6.96; N, 6.44. Found: C, 49.43; H, 6.77; N, 6.31.
2-(Octylthio)thiazol-4(5H)-one (3i): IR (KBr) 1740, 1712, 1466, 1160, 987 cm−1;1H
NMR (500 MHz, CDCl3) δ 0.88 (3H, t, J = 7.0 Hz), 1.23–1.44 (10H, m), 1.73–1.79 (2H,
m), 3.31 (2H, t, J = 7.5 Hz), 3.97 (2H, s) ppm; 13C NMR (125 MHz, CDCl3) δ 14.5, 23.0,
29.0, 29.4, 30.1, 30.6, 32.1, 34.7, 39.9, 188.1, 202.8 ppm; MS (EI): m/z 245 (M+), 198, 149,
133, 113, 86, 71, 57, 41 (100).
2-(Benzylthio)thiazol-4(5H)-one (3j): IR (KBr) ν 1732, 1695, 1414, 1196, 1063,
794 cm−1; 1H NMR (500 MHz, CDCl3) δ 3.99 (2H, s), 4.53 (2H, s), 7.25–7.33 (5H, m) ppm;
13C NMR (125 MHz, CDCl3) δ 37.9, 40.2, 129.5, 131.0, 134.0, 134.5, 187.7, 201.6 ppm; MS
(EI): m/z 222 (M-1+), 168, 123, 91 (100), 65, 45.
2-((Naphthalen-3-yl)methylthio)thiazol-4(5H)-one (3k): IR (KBr) 1736, 1704, 1458,
1
1188, 1080, 971, 774 cm−1; H NMR (500 MHz, CDCl3) δ 4.03 (2H, s), 5.10 (2H, s),
7.42–7.61 (4H, m), 7.84–8.00 (3H, m) ppm; 13C NMR (125 MHz, CDCl3) δ 36.9, 40.1,
123.6, 125.9, 126.7, 127.3, 129.0, 129.5, 129.9, 133, 131.7, 134.4, 187.9, 202.0 ppm. Anal.
Calcd for C14H11NOS2: C, 61.51; H, 4.06; N, 5.12. Found: C, 61.73; H, 4.18; N, 5.01.
Methyl 3-(4,5-dihydro-4-oxothiazol-2-ylthio)propanoate (3l): IR (KBr) 1744, 1699,
1474, 1192, 983 cm−1;1H NMR (500 MHz, CDCl3) δ 2.71 (2H, t, J = 7.0 Hz), 3.38 (2H,
t, J = 7.0 Hz), 3.55 (3H, s), 3.89 (2H, s) ppm; 13C NMR (125 MHz, CDCl3) δ 29.3, 33.8,
40.0, 52.3, 171.8, 187.8, 201.9 ppm; MS (EI): m/z 220 (M+1)+, 187, 159, 146, 133, 86, 54
(100), 46.
Methyl 3-(4,5-dihydro-4-oxothiazol-2-ylthio)-2-methylpropanoate (3m); IR (KBr)
1732, 1695, 1466, 1164, 987 cm−1; 1H NMR (500 MHz, CDCl3) δ 1.29 (3H, d, J = 7.1 Hz),
2.95 (1H, m), 3.45 (1H, dd, J = 13.6 and 8.2 Hz), 3.54 (1H, dd, J = 13.5, 5.6 Hz), 3.70
(3H, s), 3.97 (2H, s) ppm; 13C NMR (125 MHz, CDCl3) δ (ppm): 17.1, 36.5, 39.6, 40.1,
52.4, 174.8, 187.7, 202.1. MS (EI): m/z 234 (M+1)+ (100), 202, 173, 133, 101, 86, 69, 59,
46, 41.
Ethyl 3-(4,5-dihydro-4-oxothiazol-2-ylthio)propanoate (3n): IR (KBr) 1728, 1699,
1458, 1165, 983, 737 cm−1; 1H NMR (500 MHz, CDCl3) δ 1.10 (3H, t, J = 7.2 Hz), 2.68
(2H, t, J = 6.7 Hz), 3.37 (2H, t, J = 6.7 Hz), 3.88 (2H, s), 3.98 (2H, q, J = 7.1 Hz) ppm;
13C NMR (125 MHz, CDCl3) δ 14.4, 29.2, 33.9, 39.9, 61.2, 171.2, 187.7, 201.8 ppm; MS
(EI): m/z 234 (M+1)+ (100), 220, 188, 160, 133, 101, 86, 72, 55, 46.
Butyl 3-(4,5-dihydro-4-oxothiazol-2-ylthio)propanoate (3o): IR (KBr) 1736, 1699,
1462, 1168, 987 cm−1; 1H NMR (500 MHz, CDCl3) δ 0.92 (3H, t, J = 7.4 Hz), 1.35 (2H,
m), 1.62 (2H, m), 2.84 (2H, t, J = 6.7 Hz), 3.54 (2H, m, J = 6.7 Hz), 3.98 (2H, s), 4.10 (2H,